Blood-brain barrier dysfunction predicts cognitive trajectory after ischemic stroke
Authors:
- Lei XueLXLei Xue
- Olivia A JonesOJOlivia A Jones
- Lauren DragLDLauren Drag
- Kristy A. ZeraKZKristy A. Zera
- Michael MlynashMMMichael Mlynash
- Natasha S. CarmichaelNCNatasha S. Carmichael
- Chi-Hung ShuCSChi-Hung Shu
- Zuzanna BiesiadaZBZuzanna Biesiada
- David SeongDSDavid Seong
- Owen M ThomasOTOwen M Thomas
- Epiphani C. SimmonsESEpiphani C. Simmons
Preprint
Abstract
Ischemic stroke doubles the risk of dementia. 1–4 Stroke severity and location affect cognition early, 5,6 but late dementia risk is not related to infarct characteristics, nor is it reduced by preventing additional strokes, 3,6,7 and its mechanism is unknown. We identified a plasma proteomic signature of chronic stroke that was consistent with blood-brain barrier (BBB) dysfunction, including a 58% decrease in plasma levels of platelet-derived growth factor B and downregulation of its pathway compared to healthy controls. During 2 years of follow-up, the stroke-specific proteome was accentuated in stroke survivors who subsequently declined in the processing speed/executive function cognitive domain. To test BBB function, we performed dynamic contrast-enhanced MRI 6-9 months after stroke in an additional cohort and found 1.7-fold higher whole brain BBB leakage compared to controls. Finally, we compared autopsy tissue from people with infarcts and dementia at death to those with infarcts and no dementia. Those who died with dementia had dramatic loss of vascular mural cell coverage compared to those without dementia (median 0.7% vs. 27%). Thus, our proteomic, functional, and structural data implicate chronic BBB dysfunction in cognitive decline late after stroke, revealing potential proteomic and imaging biomarkers and, importantly, a novel target for intervention.Keywords
Funding Information
- Allen Frontiers Group and American Heart Association (10GRNT4140073)
- Knight Initiative for Brain Resilience
- Fondation Leducq (19CVD01)
- National Institute of Aging (P50AG047366)
- National Institute of Aging (P30AG066515)
- National Institute of Aging (R01AG074339)
- National Institute of Aging (R01AG074339)
- National Institute of Aging (P30AG072975)
- National Institute of Aging (R01AG017917)
- UKRI EPSRC
- Foundation for Anesthesia Education and Research
This publication has 71 references indexed in Scilit:
- Plasma Aβ 42 /Aβ 40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrumAlzheimer's & Dementia, 2024
- Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body DiseaseAnnals of Neurology, 2024
- A community‐endorsed open‐source lexicon for contrast agent–based perfusion MRI: A consensus guidelines report from the ISMRM Open Science Initiative for Perfusion Imaging (OSIPI)Magnetic Resonance in Medicine, 2023
- Vascular leakage caused by loss of Akt1 is associated with impaired mural cell coverageFEBS Open Bio, 2019
- Permeability of the blood–brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing–remitting multiple sclerosisAnnals of Neurology, 2018
- Risk Factors Associated With Early vs Delayed Dementia After Intracerebral HemorrhageJAMA Neurology, 2016
- Trajectory of Cognitive Decline After Incident StrokeJAMA, 2015
- Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MSJournal of Neurology, 2011
- A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosisJournal of Neurology, 2007
- Actual flip‐angle imaging in the pulsed steady state: A method for rapid three‐dimensional mapping of the transmitted radiofrequency fieldMagnetic Resonance in Medicine, 2006